Form 4 for LQDA Liquidia Corp
Accepted 2025-01-14 00:00:00 ET · period of report 2025-01-11 · accession 0001104659-25-003475 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-14 | 2025-01-14 | LQDA | Saggar Rajeev | Chief Medical Off | S - Sale | $11.78 | -6,249 | 270.4K | -2% | -$73.6K |
| D | 2025-01-14 | 2025-01-11 | LQDA | Saggar Rajeev | Chief Medical Off | A - Grant | $0.00 | +71.8K | 276.6K | +35% | $0 |
| D | 2025-01-14 | 2025-01-11 | LQDA | Saggar Rajeev | Chief Medical Off | A - Grant | $0.00 | +71.8K | 71.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-14 | S | D | 6,249 | $11.78 | 270,388 | D | — | — | (F5) These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 11, 2023 and January 11, 2024. (F3) Includes (i) 17,594 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 41,666 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 42,369 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024 and (iv) 4,918 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2025-01-11 | A | A | 71,780 | $0.00 | 276,637 | D | — | — | (F2) 25% of the RSUs shall vest on January 11, 2026 and the remaining RSUs shall vest ratably on a quarterly basis over three years thereafter. (F3) Includes (i) 17,594 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 41,666 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 42,369 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024 and (iv) 4,918 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. |
| 3 | Derivative | Performance Stock Units | 2025-01-11 | A | A | 71,780 | $0.00 | 71,780 | D | — · — to — | 71,780 Common Stock | (F6) Each performance stock unit ("PSU") converts into one share of the Issuer's common stock. (F7) On January 11, 2025, the Reporting Person was granted 71,780 PSUs. The PSUs shall vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter, and (B) the first commercial sale of YUTREPIA by the Issuer. |